IMI evaluates skin sterol lab test in key trial:
This article was originally published in Clinica
Canada's IMI International Medical Innovations is pressing on with efforts to gain regulatory approvals for new formats of its noninvasive, POC skin sterol test by starting a key study of a laboratory-based version of the product.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.